Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Vardhaman Laboratories Ltd (524796)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524796 NSE: Pharmaceuticals & Drugs | Small Cap | Vardhaman Lab Share Price
BSE Share Price
Not Listed
Not Listed
Vardhaman Laboratories Ltd (524796)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524796 NSE: Pharmaceuticals & Drugs | Small Cap | Vardhaman Lab Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 1
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
53.9
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
37.20%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹4.1 Cr.
Face Value
₹10
All Time Low / High
₹0.20 / 25.00
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -8.3% | -8.5% | -2.4% | 12.9% | -1.8% | -1% | -1.2% | -1.5% | -1.8% | -2% | - |
| Value Creation Index ⓘ | -1.6 | -1.6 | -1.2 | -0.1 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0.3 | 0.3 | 1.2 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales YoY Gr. | - | -15.6% | 359.3% | -52.4% | -100% | NA | NA | NA | NA | NA | - |
| Adj EPS ⓘ | -0.6 | -0.6 | -0.3 | 0.2 | -0.2 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 |
| YoY Gr. | - | NA | NA | NA | -217.7% | NA | NA | NA | NA | NA | - |
| BVPS (₹) ⓘ | 6.3 | 5.1 | 4.9 | 5.5 | 5.2 | 5.2 | 5.1 | 5 | 4.9 | 4.9 | 4.8 |
| Adj Net Profit ⓘ | -0.3 | -0.2 | -0.1 | 0.1 | -0.1 | -0 | -0 | -0 | -0 | -0 | -0 |
| Cash Flow from Ops. ⓘ | 0 | -0.1 | 0.4 | -1.8 | -0.1 | 0.1 | 0.3 | -0 | -0 | 0 | - |
| Debt/CF from Ops. ⓘ | 37.4 | -3.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -100% | NA | NA | NA | ||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||
| BVPSⓘ | -2.9% | -1.5% | -1.7% | -1.8% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -9.5 | -9.9 | -6.6 | 3.4 | -3.8 | -1 | -1.2 | -1.5 | -1.8 | -2 | -1.2 |
| Op. Profit Mgn % ⓘ | -71.8 | -61.5 | 1.3 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 | NAN |
| Net Profit Mgn % ⓘ | -81.9 | -86.1 | -11 | 12.1 | 0 | 0 | 0 | 0 | 0 | 0 | -INF |
| Debt to Equity ⓘ | 0.1 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 1,069 | 1,181 | 328 | 1,147 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conv. Cycle ⓘ | 1,035 | 1,102 | 41 | 689 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Valuation of Vardhaman Lab - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Vardhaman Laboratories Ltd FAQs
The current trading price of Vardhaman Lab on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Vardhaman Lab stood at ₹0.21 Cr
The latest P/E ratio of Vardhaman Lab as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Vardhaman Lab as of 31-Dec-1969 is 0.11.
The 52-week high of Vardhaman Lab is ₹0.66 and the 52-week low is ₹0.49.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vardhaman Lab is ₹0.00 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Vardhaman Laboratories Ltd
Vardhaman Laboratories Limited was incorporated on April 24, 1985 under the Companies Act, 1956, in the State of Maharashtra as Vardhaman Laboratories Private Limited and subsequently converted into a Public Limited vide special Resolution dated October 15, 1993 and obtained a fresh certificate of Incorporation to change of name on December 7, 1993 as Vardhaman Laboratories Limited, from the registrar of Companies Maharashtra, Bombay.
At present the company is engaged in manufacturing varieties of formulations and marketing under the brand name of 'SAMRAT', gained sizable popularity in the area of Western Maharashtra and Southern part of India.
The company started its operation on a small scale basis and during this time was also in the process of identifying a viable project in the Pharmaceutical industry. After a thorough and exhaustive study, the project for manufacturing the Bulk Drugs as mentioned above was conceived in December 1993.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
